These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36967611)

  • 1. Expanding strain coverage of a group A Streptococcus pilus-expressing Lactococcus lactis mucosal vaccine.
    J-Khemlani AH; Pilapitiya D; Tsai CJ; Proft T; Loh JMS
    Immunol Cell Biol; 2023 Jul; 101(6):545-555. PubMed ID: 36967611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal vaccination with pili from Group A Streptococcus expressed on Lactococcus lactis generates protective immune responses.
    Loh JMS; Lorenz N; Tsai CJ; Khemlani AHJ; Proft T
    Sci Rep; 2017 Aug; 7(1):7174. PubMed ID: 28775292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral Immunization with a Recombinant Lactococcus lactis-Expressing HIV-1 Antigen on Group A Streptococcus Pilus Induces Strong Mucosal Immunity in the Gut.
    Chamcha V; Jones A; Quigley BR; Scott JR; Amara RR
    J Immunol; 2015 Nov; 195(10):5025-34. PubMed ID: 26482408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A foreign protein incorporated on the Tip of T3 pili in Lactococcus lactis elicits systemic and mucosal immunity.
    Quigley BR; Hatkoff M; Thanassi DG; Ouattara M; Eichenbaum Z; Scott JR
    Infect Immun; 2010 Mar; 78(3):1294-303. PubMed ID: 20028807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and microbiological response of mice to intranasal inoculation with Lactococcus lactis expressing Group A Streptococcus antigens, to be used as an anti-streptococcal vaccine.
    García PC; Paillavil BA; Scioscia N; Dale JB; Legarraga P; Salazar-Echegarai FJ; Bueno SM; Kalergis AM; Wozniak A
    Microbiol Immunol; 2018 Nov; 62(11):711-719. PubMed ID: 30357922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Lactococcus lactis expressing pili from group B Streptococcus as a broad-coverage vaccine against streptococcal disease.
    Buccato S; Maione D; Rinaudo CD; Volpini G; Taddei AR; Rosini R; Telford JL; Grandi G; Margarit I
    J Infect Dis; 2006 Aug; 194(3):331-40. PubMed ID: 16826481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PilVax: A Novel Platform for the Development of Mucosal Vaccines.
    Tsai CJ; Loh JMS; Proft T
    Methods Mol Biol; 2022; 2412():399-410. PubMed ID: 34918257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with recombinant Lactococcus lactis expressing HA1-IgY Fc fusion protein provides protective mucosal immunity against H9N2 avian influenza virus in chickens.
    Zhang R; Xu T; Li Z; Li L; Li C; Li X; Wang Z; Wang S; Wang X; Zhang H
    Virol J; 2023 Apr; 20(1):76. PubMed ID: 37085816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel live vector group A streptococcal emm type 9 vaccine delivered intranasally protects mice against challenge infection with emm type 9 group A streptococci.
    Wozniak A; García P; Geoffroy EA; Aguirre DB; González SA; Sarno VA; Dale JB; Salazar-Echegarai FJ; Vera A; Bueno SM; Kalergis AM
    Clin Vaccine Immunol; 2014 Sep; 21(9):1343-9. PubMed ID: 25056362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral immunization with Lactococcus lactis-expressing EspB induces protective immune responses against Escherichia coli O157:H7 in a murine model of colonization.
    Ahmed B; Loos M; Vanrompay D; Cox E
    Vaccine; 2014 Jun; 32(31):3909-16. PubMed ID: 24877767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T4 Pili Promote Colonization and Immune Evasion Phenotypes of Nonencapsulated M4 Streptococcus pyogenes.
    Chen YH; Li SH; Yang YC; Hsu SH; Nizet V; Chang YC
    mBio; 2020 Jul; 11(4):. PubMed ID: 32694142
    [No Abstract]   [Full Text] [Related]  

  • 12. Mucosal vaccine made from live, recombinant Lactococcus lactis protects mice against pharyngeal infection with Streptococcus pyogenes.
    Mannam P; Jones KF; Geller BL
    Infect Immun; 2004 Jun; 72(6):3444-50. PubMed ID: 15155651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune Responses to Orally Administered Recombinant
    Zhang F; Zhang Z; Li X; Li J; Lv J; Ma Z; Pan L
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal immunization with Ag85B peptide 25 displayed on Lactococcus lactis using the PilVax platform induces antigen-specific B- and T-cell responses.
    Blanchett S; Tsai CJ; Sandford S; Loh JM; Huang L; Kirman JR; Proft T
    Immunol Cell Biol; 2021 Aug; 99(7):767-781. PubMed ID: 33866609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scavenger receptor gp340 aggregates group A streptococci by binding pili.
    Edwards AM; Manetti AG; Falugi F; Zingaretti C; Capo S; Buccato S; Bensi G; Telford JL; Margarit I; Grandi G
    Mol Microbiol; 2008 Jun; 68(6):1378-94. PubMed ID: 18452511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral immunization using live Lactococcus lactis co-expressing LACK and IL-12 protects BALB/c mice against Leishmania major infection.
    Hugentobler F; Di Roberto RB; Gillard J; Cousineau B
    Vaccine; 2012 Aug; 30(39):5726-32. PubMed ID: 22814408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal Vaccination with
    Diaz-Dinamarca DA; Hernandez C; Escobar DF; Soto DA; Muñoz GA; Badilla JF; Manzo RA; Carrión F; Kalergis AM; Vasquez AE
    Vaccines (Basel); 2020 Mar; 8(2):. PubMed ID: 32224855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different Group A Streptococcus pili lead to varying proinflammatory cytokine responses and virulence.
    Takahashi R; J-Khemlani AH; Loh JMS; Radcliff FJ; Proft T; Tsai CJ
    Immunol Cell Biol; 2024 Jan; 102(1):21-33. PubMed ID: 37795567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of M-Type-Specific Pilus Expression in Group A Streptococcus.
    Roshika R; Jain I; Glenaldo T; Sickler T; Musser JM; Sumby P
    J Bacteriol; 2022 Nov; 204(11):e0027022. PubMed ID: 36286511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmid Complement of Lactococcus lactis NCDO712 Reveals a Novel Pilus Gene Cluster.
    Tarazanova M; Beerthuyzen M; Siezen R; Fernandez-Gutierrez MM; de Jong A; van der Meulen S; Kok J; Bachmann H
    PLoS One; 2016; 11(12):e0167970. PubMed ID: 27941999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.